OPT101 Starts a Phase-II Clinical Trial
This is a phase-2 trial targeting CD40 cells in the immune system.
@joshualevy.bsky.socialExplore
@joshualevy.bsky.social
@joshualevy.bsky.socialOPT101 Starts a Phase-II Clinical Trial
This is a phase-2 trial targeting CD40 cells in the immune system.